[144] JBG SMITH Properties SEC Filing

Rhea-AI Filing Summary

Form 144 notice for JBG SMITH Properties (JBGS) shows a proposed sale of 1,294 common shares with an aggregate market value of $30,279.60, listed for sale approximately on 09/10/2025 on the NYSE. The report lists multiple prior open-market purchase lots for the same common stock, with acquisition dates ranging from 08/16/2017 through 08/21/2025, including a large lot of 1,000 shares acquired on 08/16/2017. A separate line reports a sale by STEVEN MUSELES of 4,622 common shares on 09/02/2025 generating gross proceeds of $97,847.74. Several filer and issuer contact fields are blank in the document, and the notice includes the standard signature representation about absence of undisclosed material information.

Insights

Securities Analyst

TL;DR: Routine Rule 144 filing showing modest proposed insider sale and multiple prior open-market purchases; appears informational, not clearly material.

The filing reports a proposed sale of 1,294 common shares valued at $30,279.60 and documents numerous historical open-market acquisitions across many dates, including a 1,000-share lot from 08/16/2017. It also discloses a separate 4,622-share sale on 09/02/2025 with $97,847.74 gross proceeds by Steven Museles. This form is a regulatory notice of intent to sell and does not include commentary on company operations or forward-looking items. Because the filing is transactional and lacks issuer financial data, its primary use is to track insider liquidity and compliance with Rule 144.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure; documents insider sales and acquisition history but provides no governance changes or material corporate developments.

The notice fulfills Rule 144 disclosure by identifying planned sales, acquisition dates, and consideration (cash). It contains the standard attestation that the seller is unaware of undisclosed material adverse information. Several administrative fields (issuer contact, filer CIK/CCC) are blank, which limits traceability in this filing alone. There is no indication in the form of executive departures, related-party transactions beyond open-market purchases, or governance actions.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1294	30279.60	61724341	09/10/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/21/2025	Open Market Purchase	Open Market			11	08/21/2025	Cash
Common	11/30/2020	Open Market Purchase	Open Market			7	11/30/2020	Cash
Common	05/27/2022	Open Market Purchase	Open Market			9	05/27/2022	Cash
Common	01/11/2021	Open Market Purchase	Open Market			8	01/11/2021	Cash
Common	03/15/2024	Open Market Purchase	Open Market			13	03/15/2024	Cash
Common	11/24/2021	Open Market Purchase	Open Market			8	11/24/2021	Cash
Common	05/22/2025	Open Market Purchase	Open Market			14	05/22/2025	Cash
Common	11/22/2022	Open Market Purchase	Open Market			13	11/22/2022	Cash
Common	01/08/2019	Open Market Purchase	Open Market			9	01/08/2019	Cash
Common	05/24/2024	Open Market Purchase	Open Market			15	05/24/2024	Cash
Common	08/21/2024	Open Market Purchase	Open Market			13	08/21/2024	Cash
Common	06/30/2023	Open Market Purchase	Open Market			17	06/30/2023	Cash
Common	08/26/2019	Open Market Purchase	Open Market			6	08/26/2019	Cash
Common	01/14/2025	Open Market Purchase	Open Market			15	01/14/2025	Cash
Common	08/27/2020	Open Market Purchase	Open Market			8	08/27/2020	Cash
Common	11/26/2018	Open Market Purchase	Open Market			6	11/26/2018	Cash
Common	11/22/2024	Open Market Purchase	Open Market			14	11/22/2024	Cash
Common	08/27/2021	Open Market Purchase	Open Market			8	08/27/2021	Cash
Common	08/26/2022	Open Market Purchase	Open Market			11	08/26/2022	Cash
Common	05/27/2021	Open Market Purchase	Open Market			7	05/27/2021	Cash
Common	01/08/2020	Open Market Purchase	Open Market			6	01/08/2020	Cash
Common	01/12/2023	Open Market Purchase	Open Market			13	01/12/2023	Cash
Common	08/31/2023	Open Market Purchase	Open Market			16	08/31/2023	Cash
Common	05/27/2020	Open Market Purchase	Open Market			8	05/27/2020	Cash
Common	05/24/2019	Open Market Purchase	Open Market			6	05/24/2019	Cash
Common	08/16/2017	Open Market Purchase	Open Market			1000	08/16/2017	Cash
Common	01/14/2022	Open Market Purchase	Open Market			8	01/14/2022	Cash
Common	11/29/2019	Open Market Purchase	Open Market			6	11/29/2019	Cash
Common	12/01/2023	Open Market Purchase	Open Market			19	12/01/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
STEVEN MUSELES 4445 Willard Avenue, Suite 400 Chevy Chase MD 20815	COMMON	09/02/2025	4622	97847.74

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for JBGS report?

The form reports a proposed sale of 1,294 common shares valued at $30,279.60, with an approximate sale date of 09/10/2025 on the NYSE.

Who sold shares recently according to the filing?

STEVEN MUSELES is listed as selling 4,622 common shares on 09/02/2025 for gross proceeds of $97,847.74.

What acquisition history is disclosed in the Form 144?

The filing lists multiple open-market purchases of common stock with acquisition dates from 08/16/2017 through 08/21/2025, including a notable 1,000-share purchase on 08/16/2017.

Does the filing disclose any undisclosed material information about JBGS operations?

The signer represents they do not know any material adverse information about the issuer that has not been publicly disclosed; the form contains no operational or financial disclosures.

On which exchange are the proposed sales to occur?

The proposed sale is listed for the NYSE.